COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity

The development of COVID-19 vaccines is critical in controlling global health issues under the COVID-19 pandemic. The subunit vaccines are the safest and most widely used vaccine platform and highly effective against a multitude of infectious diseases. An adjuvant is essential for subunit vaccines t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Soo-Kyung, Heo, Yoon-Ki, Jeong, Jei-Hyun, Ham, Su-Jin, Yum, Jung-Sun, Ahn, Byung-Cheol, Song, Chang-Seon, Chun, Eun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473206/
https://www.ncbi.nlm.nih.gov/pubmed/34579194
http://dx.doi.org/10.3390/vaccines9090957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473206/
https://www.ncbi.nlm.nih.gov/pubmed/34579194
http://dx.doi.org/10.3390/vaccines9090957

Ejemplares similares